68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients

Radiotherapy is the main therapeutic approach besides surgery of localized prostate cancer. It relies on risk stratification and exact staging. This report analyses the potential of [68Ga]Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11), a new positron emission tomography (PET) tracer targeting prostate-spe...

Full description

Saved in:
Bibliographic Details
Main Authors: Sterzing, Florian (Author) , Kratochwil, Clemens (Author) , Fiedler, Hannah (Author) , Katayama, Sonja (Author) , Habl, Gregor (Author) , Kopka, Klaus (Author) , Afshar-Oromieh, Ali (Author) , Debus, Jürgen (Author) , Haberkorn, Uwe (Author) , Giesel, Frederik L. (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: European journal of nuclear medicine and molecular imaging
Year: 2015, Volume: 43, Issue: 1, Pages: 34-41
ISSN:1619-7089
DOI:10.1007/s00259-015-3188-1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-015-3188-1
Get full text
Author Notes:Florian Sterzing, Clemens Kratochwil, Hannah Fiedler, Sonja Katayama, Gregor Habl, Klaus Kopka, Ali Afshar-Oromieh, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel
Description
Summary:Radiotherapy is the main therapeutic approach besides surgery of localized prostate cancer. It relies on risk stratification and exact staging. This report analyses the potential of [68Ga]Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11), a new positron emission tomography (PET) tracer targeting prostate-specific membrane antigen (PSMA) for prostate cancer staging and individualized radiotherapy planning.
Item Description:Im Titel ist die Zahl 68 hochgestellt
Published online: 25 September 2015
Gesehen am 15.05.2020
Physical Description:Online Resource
ISSN:1619-7089
DOI:10.1007/s00259-015-3188-1